Alveolar macrophage populations are distorted in immunocompromised patients with pneumonitis

D H Bray1, S B Squire, E Bagdades

  • 1Dept of Clinical Immunology, Royal Free Hospital and School of Medicine, London, UK.

Insights

Alveolar macrophages in HIV and transplant patients show reduced expression of key markers, indicating a defective macrophage population contributing to immunosuppression. This study highlights immune cell dysfunction in immunocompromised individuals.

Area of Science:

  • Immunology
  • Cell Biology
  • Infectious Diseases

Background:

  • Alveolar macrophages (AM) play a crucial role in lung immunity.
  • Immunocompromised states, such as human immunodeficiency virus (HIV) infection and organ transplantation, are associated with increased susceptibility to infections, often due to impaired immune responses.

Purpose of the Study:

  • To investigate the phenotypic characteristics and functional status of alveolar macrophages in patients with pneumonitis related to HIV infection and organ transplantation.
  • To compare AM populations in immunocompromised patients with those in healthy volunteers.

Main Methods:

  • Bronchoalveolar lavage (BAL) was performed to obtain alveolar macrophages from HIV-infected patients, transplant recipients, and normal volunteers.
  • Immunoperoxidase staining with monoclonal antibodies (MoAbs) was used to analyze the expression of macrophage (CD68, CD14), dendritic cell (RFD1), phagocytic (RFD7), and HLA-DR markers.

Main Results:

  • HIV-infected patients and transplant recipients showed significantly reduced expression of the pan-macrophage marker (CD68) and the dendritic cell marker (RFD1) compared to controls.
  • Phagocytic cell (RFD7) numbers were higher in transplant recipients than in HIV patients but lower than in controls.
  • HLA-DR expression on BAL cells was markedly reduced (by 90%) in both immunocompromised groups.

Conclusions:

  • Alveolar macrophages in HIV-infected and transplant recipients exhibit significant phenotypic defects, characterized by reduced expression of key surface markers.
  • These macrophage dysfunctions likely contribute to the impaired immune response and increased susceptibility to infections observed in these immunocompromised patient groups.
  • The findings suggest that targeting macrophage function could be a potential therapeutic strategy in managing pneumonitis in immunocompromised individuals.

Related Concept Videos

Alveoli and Alveolar Ducts01:26

Alveoli and Alveolar Ducts

The respiratory zone of the human body, which stands in contrast to the conducting zone, comprises the structures that actively participate in the exchange of gases. The initiation of this zone is marked by the terminal bronchioles converging into respiratory bronchioles, the tiniest bronchiole classification. The respiratory bronchioles give way to the alveolar ducts that opens into a congregation of alveoli. Actively involved in gas exchange, alveoli resemble tiny sacs similar to clusters of...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...